Hikari Power Ltd - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Hikari Power Ltd ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$142
+10.9%
12,4450.0%0.01%
+16.7%
Q2 2023$128
+33.3%
12,4450.0%0.01%
+20.0%
Q1 2023$96
+5.5%
12,4450.0%0.01%
+11.1%
Q4 2022$91
-99.9%
12,4450.0%0.01%
-10.0%
Q3 2022$90,000
-15.1%
12,4450.0%0.01%
-9.1%
Q2 2022$106,000
-5.4%
12,4450.0%0.01%
+10.0%
Q1 2022$112,000
-22.8%
12,445
+19.1%
0.01%
-28.6%
Q4 2021$145,000
+30.6%
10,4450.0%0.01%
+27.3%
Q3 2021$111,000
+18.1%
10,4450.0%0.01%
+22.2%
Q2 2021$94,000
-15.3%
10,4450.0%0.01%
-25.0%
Q1 2021$111,000
-15.9%
10,4450.0%0.01%
-20.0%
Q4 2020$132,000
+43.5%
10,4450.0%0.02%
+25.0%
Q3 2020$92,000
-81.2%
10,445
-79.3%
0.01%
-82.1%
Q2 2020$490,000
+1.4%
50,445
-69.9%
0.07%
-1.5%
Q1 2020$483,000
-32.2%
167,588
-9.6%
0.07%
-8.1%
Q4 2019$712,000
-3.1%
185,287
-0.2%
0.07%
-6.3%
Q3 2019$735,000
+43.8%
185,587
+52.9%
0.08%
+43.6%
Q2 2019$511,000
-39.5%
121,363
-1.3%
0.06%
-37.5%
Q1 2019$844,000
+86.3%
122,9720.0%0.09%
+72.5%
Q4 2018$453,000122,9720.05%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$23,143,0002.13%
Omega Fund Management, LLC 1,284,900$11,564,0001.31%
Avidity Partners Management LP 1,495,000$13,455,0000.36%
Samsara BioCapital, LLC 275,169$2,477,0000.31%
Orbimed Advisors 3,070,955$27,639,0000.28%
Ikarian Capital, LLC 300,454$2,704,0000.22%
TIGER MANAGEMENT L.L.C. 137,728$1,240,0000.22%
DAFNA Capital Management LLC 113,302$1,020,0000.21%
EcoR1 Capital, LLC 522,635$4,704,0000.18%
Artal Group S.A. 593,030$5,337,0000.11%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders